The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

ConditionsAdenocarcinoma of the Colon Adenocarcinoma of the Rectum Stage I Colorectal Cancer Stage II Colorectal Cancer Stage III Colorectal Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorCase Comprehensive Cancer Center

About this trial

The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to standard testing.

Eligibility criteria

Qualifiers

Diagnosis of stage I, II or III adenocarcinoma of the colon or rectum

Receipt of preoperative colonoscopy

Receipt of bowel resection; use of adjuvant chemotherapy or radiation therapy as clinically indicated

Disqualifiers

Stage IV colorectal cancer

Surgical treatment with subtotal colectomy or total proctocolectomy

Diagnosis of inflammatory bowel disease (ulcerative colitis or Crohn's disease)

Diagnosis of polyposis syndrome including Lynch syndrome or familial polyposis

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Locations

University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center44106, ClevelandOhio, United States

Sponsors and collaborators

Case Comprehensive Cancer Center

Lead sponsor

Source ClinicalTrials.gov